Frank Torti - 23 Dec 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Frank Torti
Issuer symbol
ROIV
Transactions as of
23 Dec 2025
Net transactions value
+$2,479,180
Form type
4
Filing time
29 Dec 2025, 21:00:23 UTC
Previous filing
01 Aug 2025
Next filing
23 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Torti Frank President and Vant Chair C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM By: /s/ Jo Chen, as Attorney-in-Fact for Frank Torti 29 Dec 2025 0001647805

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $3,937,281 +175,380 +1.3% $22.45 13,911,927 23 Dec 2025 Direct F1
transaction ROIV Common Shares Other $1,458,101 -64,891 -0.47% $22.47 13,847,036 24 Dec 2025 Direct F2, F3
transaction ROIV Common Shares Gift $0 -110,489 -0.8% $0.000000 13,736,547 24 Dec 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange.
F2 The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $22.45 to $22.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
F3 Represents a sale of Common Shares only to cover estimated taxes due in connection with the exchange described in footnote 1.
F4 The Reporting Person donated 110,489 Common Shares to a donor advised fund, which will use the gifted Common Shares for charitable purposes.